. "Kizek, Ren\u00E9" . "Kuka\u010Dka, Ji\u0159\u00ED" . . "12"^^ . . . . "Association of formation and progression of a tumour disease and level of metallothioneins"@en . . "Horakov\u00E1, Zuzana" . "Hrab\u011Bta, Jan" . "K\u0159\u00ED\u017Ekov\u00E1, So\u0148a" . "Association of formation and progression of a tumour disease and level of metallothioneins" . "43210" . . "978-80-210-4526-2" . . "Brno" . "XII. pracovn\u00ED setk\u00E1n\u00ED biochemik\u016F a molekul\u00E1rn\u00EDch biolog\u016F" . "Spojen\u00ED tvorby a progrese n\u00E1dorov\u00E9ho onemocn\u011Bn\u00ED s \u00FArovn\u00ED metalothioneinu"@cs . "Masarykova univerzita" . "Adam, Vojt\u011Bch" . "Pr\u016F\u0161a, Richard" . "Association of formation and progression of a tumour disease and level of metallothioneins"@en . "Spojen\u00ED tvorby a progrese n\u00E1dorov\u00E9ho onemocn\u011Bn\u00ED s \u00FArovn\u00ED metalothioneinu"@cs . "A tumour disease or cancer, %22plague of the world%22, are words, which present a threat to humans as well as a subject of investigation for broaden scientific public. The success of treatment of the disease depends on many factors such as prevention, early and sensitive diagnostics. That means the sooner a cancer is detected, the better the chances to treat it successfully. In the last decade, several reports disclosed metallothioneins (MTs) expression as a useful prognostic factor for tumour progression and drug resistance in a variety of malignancies e.g. leukaemia, melanoma, breast, ovarian, renal, lung, pancreatic, gall bladder, esophageal, and basal cell carcinoma. The present work reports on investigation of involving of MTs in early detection of the disease as new tumour marker." . "1"^^ . "S\u00FDkorov\u00E1, E." . . "RIV/62156489:43210/08:00121294" . "RIV/62156489:43210/08:00121294!RIV09-AV0-43210___" . "357168" . "A tumour disease or cancer, %22plague of the world%22, are words, which present a threat to humans as well as a subject of investigation for broaden scientific public. The success of treatment of the disease depends on many factors such as prevention, early and sensitive diagnostics. That means the sooner a cancer is detected, the better the chances to treat it successfully. In the last decade, several reports disclosed metallothioneins (MTs) expression as a useful prognostic factor for tumour progression and drug resistance in a variety of malignancies e.g. leukaemia, melanoma, breast, ovarian, renal, lung, pancreatic, gall bladder, esophageal, and basal cell carcinoma. The present work reports on investigation of involving of MTs in early detection of the disease as new tumour marker."@en . . . "Eckschlager, Tom\u00E1\u0161" . "4"^^ . "Fabrik, Ivo" . . "Association of formation and progression of a tumour disease and level of metallothioneins" . "P(IAA401990701)" . . "Z\u00EDtka, Ond\u0159ej" . "[F80EC6C42B17]" . "Tumorov\u00E9 choroby jsou ve sv\u011Bte roz\u0161\u00ED\u0159en\u00ED a jejich l\u00E9\u010Dba je intenzivn\u011B zkoum\u00E1na. \u00DAsp\u011Bch l\u00E9\u010Dby je z\u00E1visl\u00ED na mnoho faktor\u016F jako je preventivn\u00ED a citliv\u00E1 diagnostika. V minul\u00E9m desetilet\u00ED n\u011Bkolik publikac\u00ED d\u00E1valo expresi metalothioneinu do souvislosti s p\u0159\u00EDtomnost\u00ED n\u00E1dorov\u00E9ho onemocn\u011Bn\u00ED jako je leuk\u00E9mie, n\u00E1dor plic, vaje\u010Dn\u00EDk\u016F, pankreatu. V t\u00E9to pr\u00E1ci uv\u00E1d\u00EDme shrnut\u00ED v\u00FDzkumu metalothionein\u016F v \u010Dasn\u00E9 detekci a diagnostice tumorov\u00FDch marker\u016F."@cs . . . "metallothionein; tumour diseas"@en . . "Binkov\u00E1, Hana" . .